Selective targeting of visceral adiposity by polycation nanomedicine
Source abstract
Abstract
Obesity is a pandemic health problem with poor solutions, especially for targeted treatment. Here we develop a polycation-based nanomedicine polyamidoamine generation 3 (P-G3) that-when delivered intraperitoneally-selectively targets visceral fat due to its high charge density. Moreover, P-G3 treatment of obese mice inhibits visceral adiposity, increases energy expenditure, prevents obesity and alleviates the associated metabolic dysfunctions. In vitro adipogenesis models and single-cell RNA sequencing revealed that P-G3 uncouples adipocyte lipid synthesis and storage from adipocyte development to create adipocytes that possess normal functions but are deficient in hypertrophic growth, at least through synergistically modulating nutrient-sensing signalling pathways. The visceral fat distribution of P-G3 is enhanced by modifying P-G3 with cholesterol to form lipophilic nanoparticles, which is effective in treating obesity. Our study highlights a strategy to target visceral adiposity and suggests that cationic nanomaterials could be exploited for treating metabolic diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Adipose Tissue and Metabolism · Immune cells in cancer · Adipokines, Inflammation, and Metabolic Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Danaei, G. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6, e1000058 (2009).10.1371/journal.pmed.1000058 ↗
2. Verboven, K. et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci. Rep. 8, 4677 (2018).10.1038/s41598-018-22962-x ↗
3. Kajimura, S., Spiegelman, B. M. & Seale, P. Brown and beige fat: physiological roles beyond heat generation. Cell Metab. 22, 546–559 (2015).10.1016/j.cmet.2015.09.007 ↗
4. Huffman, D. M. & Barzilai, N. Role of visceral adipose tissue in aging. Biochim. Biophys. Acta 1790, 1117–1123 (2009).10.1016/j.bbagen.2009.01.008 ↗
5. Svenson, S. & Tomalia, D. A. Dendrimers in biomedical applications—reflections on the field. Adv. Drug Deliv. Rev. 57, 2106–2129 (2005).10.1016/j.addr.2005.09.018 ↗
6. Lee, J. et al. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl Acad. Sci. USA 108, 14055–14060 (2011).10.1073/pnas.1105777108 ↗
7. Lee, J. et al. Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis. Biomaterials 120, 94–102 (2017).10.1016/j.biomaterials.2016.12.024 ↗
8. Pisetsky, D. S., Lee, J., Leong, K. W. & Sullenger, B. A. Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack. Expert Rev. Clin. Immunol. 8, 1–3 (2012).10.1586/eci.11.82 ↗
9. Mariman, E. C. & Wang, P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell. Mol. Life Sci. 67, 1277–1292 (2010).10.1007/s00018-010-0263-4 ↗
10. Puri, S., Coulson-Thomas, Y. M., Gesteira, T. F. & Coulson-Thomas, V. J. Distribution and function of glycosaminoglycans and proteoglycans in the development, homeostasis and pathology of the ocular surface. Front Cell Dev. Biol. 8, 731 (2020).10.3389/fcell.2020.00731 ↗
11. Esfand, R. & Tomalia, D. A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Disco. Today 6, 427–436 (2001).10.1016/S1359-6446(01)01757-3 ↗
12. Pajvani, U. B. et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 11, 797–803 (2005).10.1038/nm1262 ↗
13. Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C. & Lazar, M. A. Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. Proc. Natl Acad. Sci. USA 110, 18656–18661 (2013).10.1073/pnas.1314863110 ↗
14. Farmer, S. R. Transcriptional control of adipocyte formation. Cell Metab. 4, 263–273 (2006).10.1016/j.cmet.2006.07.001 ↗
15. Li, D. et al. Distinct functions of PPARγ isoforms in regulating adipocyte plasticity. Biochem. Biophys. Res. Commun. 481, 132–138 (2016).10.1016/j.bbrc.2016.10.152 ↗
16. La Manno, G. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).10.1038/s41586-018-0414-6 ↗
17. Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).10.1038/s41587-020-0591-3 ↗
18. Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).10.1038/nmeth.4463 ↗
19. Hwang, M. E., Keswani, R. K. & Pack, D. W. Dependence of PEI and PAMAM gene delivery on clathrin- and caveolin-dependent trafficking pathways. Pharm. Res. 32, 2051–2059 (2015).10.1007/s11095-014-1598-6 ↗
20. Fox, L. J., Richardson, R. M. & Briscoe, W. H. PAMAM dendrimer-cell membrane interactions. Adv. Colloid Interface Sci. 257, 1–18 (2018).10.1016/j.cis.2018.06.005 ↗
21. Kitchens, K. M., Foraker, A. B., Kolhatkar, R. B., Swaan, P. W. & Ghandehari, H. Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm. Res. 24, 2138–2145 (2007).10.1007/s11095-007-9415-0 ↗
22. Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).10.1016/j.cell.2017.02.004 ↗
23. Chung, C. Y. et al. Covalent targeting of the vacuolar H(+)-ATPase activates autophagy via mTORC1 inhibition. Nat. Chem. Biol. 15, 776–785 (2019).10.1038/s41589-019-0308-4 ↗
24. Rajman, L., Chwalek, K. & Sinclair, D. A. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 27, 529–547 (2018).10.1016/j.cmet.2018.02.011 ↗
25. Ryu, K. W. et al. Metabolic regulation of transcription through compartmentalized NAD(+) biosynthesis. Science 360, eaan5780 (2018).10.1126/science.aan5780 ↗
26. Zhang, Y. et al. Locally induced adipose tissue browning by microneedle patch for obesity treatment. ACS Nano 11, 9223–9230 (2017).10.1021/acsnano.7b04348 ↗
27. Andrew, M. S. et al. Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons. Surg. Obes. Relat. Dis. 14, 833–841 (2018).10.1016/j.soard.2018.03.004 ↗
28. Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242–258 (2019).10.1038/s41580-018-0093-z ↗
29. Tandon, P., Wafer, R. & Minchin, J. E. N. Adipose morphology and metabolic disease. J. Exp. Biol. 221, jeb164970 (2018).10.1242/jeb.164970 ↗
30. Acosta, J. R. et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 59, 560–570 (2016).10.1007/s00125-015-3810-6 ↗
31. Brown, J. M. et al. Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J. Biol. Chem. 279, 26735–26747 (2004).10.1074/jbc.M401766200 ↗
32. House, R. L. et al. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol. Genomics 21, 351–361 (2005).10.1152/physiolgenomics.00244.2004 ↗
33. Van, R. L., Bayliss, C. E. & Roncari, D. A. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J. Clin. Invest. 58, 699–704 (1976).10.1172/JCI108516 ↗
34. Negrel, R., Grimaldi, P. & Ailhaud, G. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. Proc. Natl Acad. Sci. USA 75, 6054–6058 (1978).10.1073/pnas.75.12.6054 ↗
35. Verges, B., Walter, T. & Cariou, B. Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism. Eur. J. Endocrinol. 170, R43–R55 (2014).10.1530/EJE-13-0586 ↗
36. Zhang, Y. & Chua, S. Jr. Leptin function and regulation. Compr. Physiol. 8, 351–369 (2017).10.1002/cphy.c160041 ↗
37. Leong, K. W., & Qiang, L. Targeting obesity: eliminating visceral fat. Columbia Engineering Magazine (spring 2022).
38. Higuchi, S. et al. Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice. Gut 69, 1620–1628 (2020).10.1136/gutjnl-2019-319693 ↗
39. Brown, B. N. et al. Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix. Tissue Eng. Part C Methods 17, 411–421 (2011).10.1089/ten.tec.2010.0342 ↗
40. Lee, M. J. & Fried, S. K. Optimal protocol for the differentiation and metabolic analysis of human adipose stromal cells. Methods Enzymol. 538, 49–65 (2014).10.1016/B978-0-12-800280-3.00004-9 ↗
41. Lee, M. J., Gong, D. W., Burkey, B. F. & Fried, S. K. Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am. J. Physiol. Endocrinol. Metab. 300, E571–E580 (2011).10.1152/ajpendo.00231.2010 ↗